Form4insider filings, from the source

Company · CIK 0001372299 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

Ocugen, Inc. · OCGN

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $26k · 1sales $589k · 1net −$563k
$10k$10k$100k$100k$1M$1MbuyssalesMar 28Apr 27May 28Jun 28Jul 29Aug 28Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 9, 2026 SForm 4 →Sep 11, 9:13 pm EDTShankar MusunuriChief Executive Officer, Director525,991$1.12$589,1101,088,035−32.6%10b5-1
Jun 15, 2026 PForm 4 →Jun 17, 4:13 pm EDTTreerita Essalima Johnson-GreeneChief Financial Officer21,000$1.23$25,830521,000+4.20%

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 11, 2026 AForm 4 →Jun 15, 4:35 pm EDTUday KompellaDirector170,100——170,100—
Jun 11, 2026 AForm 4 →Jun 15, 4:33 pm EDTSatishchandran ChandrasekharDirector170,100——170,100—
Jun 11, 2026 AForm 4 →Jun 15, 4:32 pm EDTKirsten CastilloDirector170,100——170,100—
Jun 11, 2026 AForm 4 →Jun 15, 4:31 pm EDTJunge ZhangDirector170,100——170,100—
Jun 11, 2026 AForm 4 →Jun 15, 4:30 pm EDTBlaise ColemanDirector170,100——170,100—